CXCL8 and hepatocellular carcinoma: IL‐8 additionally triggers EMT changes in thyroid cancer cells via the AKT/Slug pathway (Visciano et al., 2015) and in hepatocellular carcinoma, via JAK2/STAT3 activation and Snail1 expression (Fu et al., 2015).